City of Hope researchers demonstrate proof of concept for a novel targeted therapy for pancreatic cancer, exploiting transcription-replication conflicts to combat treatment resistance.

Researchers at City of Hope have identified a new molecular target for treating pancreatic cancer, reports a Gastroenterology study. Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest ...

The health system, taking part in HealthLeaders’ AI in Clinical Care Mastermind program, says AI has the potential to ...

Dr. Fong has focused on gene therapy for over two decades, engineering viruses and immune cells to kill cancer. His City of Hope team developed CF33, a cancer-fighting virus that has been shown to ...

Atebimetinib with modified chemo led to 94% 6-month survival rates in first-line pancreatic cancer, with durable responses ...

The grant awarded earlier this month is going to a team at City of Hope’s Beckman Research Institute that will also test biomarker therapies for patients with non-small-cell lung cancer, the prevalent ...

City of Hope’s Beckman Research Institute researchers will also test new biomarker-guided therapies in near real time NSCLC, ...

Last year City of Hope received a historic $150 million gift to fund pancreatic cancer research from two entrepreneur-philanthropists: A. Emmet Stephenson Jr. and his daughter, Tessa Stephenson Brand.

Last year City of Hope received a historic $150 million gift to fund pancreatic cancer research from two entrepreneur-philanthropists: A. Emmet Stephenson Jr. and his daughter, Tessa Stephenson Brand.

Researchers at City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the U.S. with its National Medical Center named top 5 in the nation for cancer by ...